PRO: Patients with metastatic/recurrent cervical cancer should be treated with cisplatin plus paclitaxel

Clinical Ovarian Cancer

Volumn 4, Issue 2, 2011, Pages 90-93

  Tewari, Krishnansu S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; TOPOTECAN;

ADVANCED CANCER; ANEMIA; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; DRUG TOLERABILITY; FATIGUE; HUMAN; LYMPH NODE METASTASIS; METASTASIS; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT CANCER; REVIEW; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

EID: 84859171787     PISSN: 19414390     EISSN: 19414404     Source Type: Journal    
DOI: 10.1016/j.cloc.2012.02.014     Document Type: Note

References (27)

1. B.J. Monk, and K.S. Tewari Invasive cervical cancer P.J. DiSaia, W.T. Creasman, Clinical Gynecologic Oncology 7th Edition 2007 Mosby Publishers Philadelphia, PA
2. A. Jemal, R. Siegel, E. Ward et al. Cancer Statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. T.C. Wright Jr, L.S. Massad, C.J. Dunton et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests J Low Genit Tract Dis 11 2007 201 222 (Pubitemid 47530909)
4. S.M. Garland, M. Hernandez-Avila, and C.M. Wheeler Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 2007 1928 1943 (Pubitemid 46740303)
5. J. Paavonen, P. Naud, and J. Salmerón et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomized study in young women Lancet 374 2009 301 314
6. A. Sedlis, B.N. Bundy, and M.Z. Rotman et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study Gynecol Oncol 73 1999 177 183 (Pubitemid 29215728)
7. W.A. Peters III, P.Y. Liu, R.J. Barrett II et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
8. B.J. Monk, K.S. Tewari, W.J. Koh Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions J Clin Oncol 27 2007 2952 2965 (Pubitemid 47123160)
9. H.M. Keys, B.N. Bundy, and F.B. Stehman et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
10. M. Morris, P.J. Eifel, and J. Lu et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1999 1137 1143 (Pubitemid 29177872)
11. C.W. Whitney, W. Sause, and B.N. Bundy et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J Clin Oncol 17 1999 1339 1348 (Pubitemid 29220838)
12. P.G. Rose, B.N. Bundy, and E.B. Watkins et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153 (Pubitemid 29177873)
13. K.S. Tewari, B.J. Monk Gynecologic Oncology Group trials of chemotherapy for metastatic and recurrent cervical cancer Curr Oncol Rep 7 2005 419 434 (Pubitemid 41684228)
14. P. Bonomi, J.A. Blessing, and F.B. Stehman et al. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 3 1985 1079 1085 (Pubitemid 15004828)
15. J.T. Thigpen, J.A. Blessing, and P.J. DiSaia et al. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study Gynecol Oncol 32 1989 198 202 (Pubitemid 19041962)
16. W.P. McGuire III, J. Arseneau, and J.A. Blessing et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study J Clin Oncol 7 1989 1462 1468
17. G.A. Omura, J.A. Blessing, and L. Vaccarello et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 15 1997 165 171 (Pubitemid 27020569)
18. J.D. Bloss, J.A. Blessing, and B.C. Behrens et al. Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 20 2002 1832 1837 (Pubitemid 34273273)
19. K.S. Tewari, B.J. Monk Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group Semin Oncol 36 2009 170 180
20. D.H. Moore, J.A. Blessing, and R.P. McQuellon et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study J Clin Oncol 22 2004 3113 3119 (Pubitemid 41103724)
21. H.J. Long III, B.N. Bundy, and E.C. Grendys et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study J Clin Oncol 23 2005 4626 4633 (Pubitemid 46224065)
22. H.J. Long III, B.J. Monk, H. Huang Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: a Gynecologic Oncology Group study Gynecol Oncol 100 2006 537 543 (Pubitemid 43246869)
23. D.H. Moore, C. Tian, and B.J. Monk et al. Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 116 2010 44 49
24. B.J. Monk, M.W. Sill, and D.S. McMeekin et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study J Clin Oncol 27 2009 4649 4655
25. K.S. Tewari, B.J. Monk Beyond platinum for metastatic and recurrent carcinoma of the cervix Onkologie 32 2009 595 597
26. J.T. Qui, K.C. Ho, and C.H. Lai et al. Supraclavicular lymph node metastases in cervical cancer Eur J Gynaecol Oncol 28 2007 33 38 (Pubitemid 46414322)
27. Paclitaxel and cisplatin or topotecan with or without bevacizumab in treating patients with stage IVB, recurrent, or persistent cervical cancer ClinicalTrials.gov [Web site] http://clinicaltrials.gov/ct2/show/NCT00803062 Accessed: May 9, 2010